Records containing: Opioid-related Disorders
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-04-03Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
-
CLINICAL_TRIALS study record update · 2019-04-18Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study®
-
CLINICAL_TRIALS study record update · 2019-04-10Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
-
CLINICAL_TRIALS study record update · 2018-11-02An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2018-09-13BUPrenorphine Facilitated Access and Supportive Treatment--AIM 3
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-05-03ClinicalTrials.gov study NCT02360007
-
CLINICAL_TRIALS study record update · 2018-03-29An Open-Label, Long-Term Safety and Tolerability Study of Depot Buprenorphine (RBP-6000) in Treatment-Seeking Subjects With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2017-05-10Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study
-
CLINICAL_TRIALS study record update · 2017-03-03Evaluation of Opioid Antagonist Activity in Humans
-
CLINICAL_TRIALS study record update · 2016-12-05Reinforcing Effects of Intravenous Buprenorphine Versus Buprenorphine/Naloxone in Buprenorphine-maintained Intravenous Drug Users (P05207)
-
CLINICAL_TRIALS study record update · 2016-10-05Extended Release (ER) / Long-acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Assessment 5.1: Surveillance of Emergency Department Visits and Hospitalizations for Opioid Overdose and Poisoning Events
-
CLINICAL_TRIALS study record update · 2016-09-29COMT Val158Met Polymorphism in Opiate-using Subjects Without Lifetime Opiate Dependence
-
CLINICAL_TRIALS study record update · 2016-09-13Extended Release/Long Acting (ER/LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Medical Examiner Surveillance Monitoring Protocol
-
CLINICAL_TRIALS study record update · 2016-08-25Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS): RADARS® System Surveillance Protocol
-
CLINICAL_TRIALS study record update · 2015-05-28Pilot Evaluation of the "Tailored Telephone Intervention Delivered by Peers to Prevent Recurring Opioid-Overdoses"
-
CLINICAL_TRIALS study record update · 2014-05-09Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
-
CLINICAL_TRIALS study record update · 2012-07-27A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Standard Medical Management or Enhanced Medical Management for Opioid Analgesic Dependence
-
CLINICAL_TRIALS study record update · 2012-06-08A Randomized, Double-Blind, Placebo-Controlled, 3 Way Crossover Study Evaluating The Relative Abuse Potential Of Crushed Embeda Compared To Morphine Sulfate Controlled Release Tablets (Crushed) And Placebo In Non-Dependent, Recreational Opioid Users Following Intranasal Administration
-
CLINICAL_TRIALS study record update · 2012-02-24Open-Label, Single-Dose, Randomized, 5-Period, 5-Way Crossover Study To Evaluate The Dose Proportionality And The Effects Of Food On The Bioavailability Of Acurox Tablets In Healthy Volunteers